J.H. Whitney Acquires TIDI Products, LLC
NJ.H. Whitney Capital Partners, LLC (J.H. Whitney), a middle-market private equity firm, announced today that it acquired TIDI Products, LLC.
Based in Neenah, Wis., TIDI is a leading provider of disposable infection prevention products used in dental practices and in acute-care settings. The companys core products include patient gowns and draping, dental bibs and towels, tray covers, equipment covers and sheaths, and barrier products. With more than 40 years of experience in the industry, TIDI enjoys a leading market position and strong relationships with the nations leading healthcare distributors.
TIDI has worked hard to develop an industry-leading platform that delivers great service and value to our customers, says Kevin McNamara, CEO and president of TIDI. We look forward to partnering with J.H. Whitney and believe that together we can enhance the next level of growth for TIDI.
TIDI products represent the first line of defense in the fight against healthcare acquired infections a key priority in todays healthcare environment, says Brian Cherry, managing director at J.H. Whitney. We have partnered with an experienced management team with an exceptional track record of customer service and financial performance. Together we are committed to the continued growth of TIDI.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
